Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium

被引：0

作者：

Helal, M ^{[1
]}

Messiha, N ^{[1
]}

Amayem, A ^{[1
]}

ElMaghraby, A ^{[1
]}

Elsherif, Z ^{[1
]}

Dabees, M ^{[1
]}

机构：

[1] RES INST OPHTHALMOL,CAIRO,EGYPT

来源：

OPHTHALMIC SURGERY AND LASERS | 1996年 / 27卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

BACKGROUND AND OBJECTIVE: To evaluate the safety and efficacy of two different regimens of mitomycin-C (MMC) application as adjunctive chemotherapy in the treatment of pterygia. PATIENTS AND METHODS: One hundred fifty-six patients underwent pterygium excision using the bare sclera technique. They were randomly assigned to have either 0.1 mg/ml of MMC applied to the bare sclera for 3 minutes intraoperatively, or 0.05-mg/ml drops applied topically for 2 weeks postoperatively. The mean follow-up period was 11 months (range 7 to 17). RESULTS: Complications with the intraoperative MMC included 5 cases of recurrence (5.75%), 2 cases of superficial punctate keratitis (SPK), and 3 cases of delayed conjunctival wound healing. Topical MMC led to 6 cases of recurrence (6.9%), 5 cases of SPK, 4 cases of delayed conjunctival wound healing, and 2 cases of mild iritis. CONCLUSION: A single, intraoperative application of MMC is a simple, effective alternative adjunctive treatment for pterygium.

引用

页码：674 / 678

页数：5

共 37 条

[11]

CRAIG CR, 1990, MODERN PHARM, P807

[12]

Dimitry TJ., 1937, AM J OPHTHALMOL, V20, P40, DOI [10.1016/S0002-9394%2837%2992726-0., DOI 10.1016/S0002-9394%2837%2992726-0]

[13]

DOWLUT MS, 1981, CAN J OPHTHALMOL, V16, P119

[14]

DUKEELDER S, 1965, SYSTEM OPHTHALMOLOGY, V81, P573